Healthcare provider profile · identity verified

David Hoffius, MD

Family Practice · GRAND RAPIDS, MI · NPI 1689628596

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	603	170
Levothyroxine Sodium	Levothyroxine Sodium	342	90
Lisinopril	Lisinopril	333	88
Omeprazole	Omeprazole	324	94
Amlodipine Besylate	Amlodipine Besylate	286	81
Hydrochlorothiazide	Hydrochlorothiazide	278	77
Losartan Potassium	Losartan Potassium	276	80
Simvastatin	Simvastatin	203	60
Pravastatin Sodium	Pravastatin Sodium	155	43
Metoprolol Succinate	Metoprolol Succinate	154	45
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	141	42
Metformin Hcl Er	Metformin Hcl	128	31
Tamsulosin Hcl	Tamsulosin Hcl	127	34
Metformin Hcl	Metformin Hcl	126	38
Gabapentin	Gabapentin	125	33
Trazodone Hcl	Trazodone Hcl	125	34
Allopurinol	Allopurinol	121	28
Rosuvastatin Calcium	Rosuvastatin Calcium	120	35
Finasteride	Finasteride	111	28
Escitalopram Oxalate	Escitalopram Oxalate	97	25
Sertraline Hcl	Sertraline Hcl	97	22
Tramadol Hcl	Tramadol Hcl	97	18
Alprazolam	Alprazolam	90	20
Glipizide Er	Glipizide	90	23
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	88	22
Metoprolol Tartrate	Metoprolol Tartrate	85	24
Montelukast Sodium	Montelukast Sodium	83	24
Duloxetine Hcl	Duloxetine Hcl	81	23
Furosemide	Furosemide	77	24
Zolpidem Tartrate	Zolpidem Tartrate	76	18
Meloxicam	Meloxicam	73	31
Fluoxetine Hcl	Fluoxetine Hcl	72	17
Carvedilol	Carvedilol	71	20
Pantoprazole Sodium	Pantoprazole Sodium	68	22
Fluticasone Propionate	Fluticasone Propionate	65	28
Doxazosin Mesylate	Doxazosin Mesylate	55	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	54	13
Atenolol	Atenolol	51	13
Eliquis	Apixaban	51	12
Potassium Chloride	Potassium Chloride	51	14
Citalopram Hbr	Citalopram Hydrobromide	50	14
Trulicity	Dulaglutide	50	suppressed
Alendronate Sodium	Alendronate Sodium	47	13
Farxiga	Dapagliflozin Propanediol	47	11
Prednisone	Prednisone	47	39
Famotidine	Famotidine	43	13
Buspirone Hcl	Buspirone Hcl	41	suppressed
Lorazepam	Lorazepam	39	suppressed
Spironolactone	Spironolactone	37	13
Lovastatin	Lovastatin	36	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	35	suppressed
Xarelto	Rivaroxaban	35	suppressed
Gemfibrozil	Gemfibrozil	34	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	33	17
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	33	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	30	11
Venlafaxine Hcl Er	Venlafaxine Hcl	30	suppressed
Warfarin Sodium	Warfarin Sodium	30	suppressed
Amoxicillin	Amoxicillin	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Colchicine	Colchicine	28	suppressed
Ibuprofen	Ibuprofen	28	suppressed
Clonidine Hcl	Clonidine Hcl	26	suppressed
Lamotrigine	Lamotrigine	26	suppressed
Lansoprazole	Lansoprazole	26	suppressed
Mounjaro	Tirzepatide	26	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	26	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	25	suppressed
Glipizide	Glipizide	24	suppressed
Propranolol Hcl	Propranolol Hcl	24	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	24	20
Valacyclovir	Valacyclovir Hcl	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	23	20
Dutasteride	Dutasteride	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	22	15
Donepezil Hcl	Donepezil Hcl	22	suppressed
Azelastine Hcl	Azelastine Hcl	21	suppressed
Cephalexin	Cephalexin	21	14
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	21	suppressed
Hydrocortisone	Hydrocortisone	21	13
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Sildenafil Citrate	Sildenafil Citrate	21	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	20	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Diclofenac Sodium-Misoprostol	Diclofenac Sodium/Misoprostol	20	suppressed
Estradiol	Estradiol	20	suppressed
Indapamide	Indapamide	20	suppressed
Bupropion Hcl Sr	Bupropion Hcl	19	suppressed
Methylprednisolone	Methylprednisolone	19	19
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	17	suppressed
Tizanidine Hcl	Tizanidine Hcl	17	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	16	16
Diclofenac Sodium	Diclofenac Sodium	16	11
Klor-Con M20	Potassium Chloride	16	suppressed
Mirtazapine	Mirtazapine	16	suppressed
Benzonatate	Benzonatate	15	14
Fluconazole	Fluconazole	15	15
Qvar Redihaler	Beclomethasone Dipropionate	15	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	15	14
Synthroid	Levothyroxine Sodium	15	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	14	suppressed
Ezetimibe	Ezetimibe	14	suppressed
Nystatin	Nystatin	14	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	14	suppressed
Terbinafine Hcl	Terbinafine Hcl	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Novolin N	Insulin Nph Human Isophane	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Phenytoin Sodium Extended	Phenytoin Sodium Extended	13	suppressed
Ramipril	Ramipril	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	12	suppressed
Loperamide	Loperamide Hcl	12	suppressed
Memantine Hcl	Memantine Hcl	12	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	12	suppressed
Ozempic	Semaglutide	12	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	11	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	11	suppressed
Jardiance	Empagliflozin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error